Trials / Sponsors / Albert B. Sabin Vaccine Institute

Albert B. Sabin Vaccine Institute

Academic / Other · 11 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya Cholera Vaccination	Phase 4	2025-10-31
Active Not Recruiting	A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Ade Ebola Sudan Virus Disease	Phase 2	2025-06-26
Active Not Recruiting	A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Ade Marburg Virus Disease	Phase 2	2025-04-14
Completed	Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults Ebola Sudan Virus Disease	Phase 2	2024-07-15
Completed	Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults Marburg Virus Disease	Phase 2	2023-10-19
Completed	Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil COVID-19	Phase 4	2022-07-05
Completed	Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults Ebola Virus Disease, Marburg Virus Disease	Phase 1	2021-01-06
Completed	Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptom Dengue	—	2017-08-01
Completed	Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of Br Hookworm Infection	N/A	2009-08-01
Completed	Development of a Skin Test for the Na-ASP-2 Hookworm Antigen Hookworm Infection, Allergy	N/A	2008-03-01
Terminated	Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults Hookworm Infection	Phase 1	2007-05-01